Stroke
1933–1967 · 1 of 5
Cerebrovascular Embolism and Revascularization
1933–1967
Vascular BiologyCardiovascular DiseaseCardiologyVascular SurgeryCardiovascular ResearchThrombosisNephrologyCerebrovascular DiseaseHematologyVascular Disease
The dominant pattern combined physiological analysis of cerebral perfusion with evolving vascular interventions. Research tracked how systemic hemodynamics influence cerebral blood flow, while carotid surgery and endovascular approaches emerged, guided by hemodynamic assessments and arteriography. Epidemiology and risk factors, including age and hypertension, shaped disease burden and therapeutic risk stratification, with retinal emboli acting as proxies for cerebral risk.
The period saw seminal works such as Cerebral Embolism (1965), which advanced the classification of embolic stroke and prevention strategies, shaping later imaging and diagnostics. The Natural History of Subarachnoid Hemorrhage, Intracranial Aneurysms and Arteriovenous Malformations (1966) mapped outcomes and risk factors, guiding surgical and endovascular management and prognosis. Earlier studies like Reconstruction of Internal Carotid Artery in a Patient with Intermittent Attacks of Hemiplegia (1954) documented early carotid revascularization, catalyzing endarterectomy programs; and Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis (1957) highlighted elderly prognosis and rehabilitation planning.
1968–1997
Vascular BiologyCardiovascular DiseaseCardiologyCardiovascular ResearchThrombosisVascular SurgeryCerebrovascular DiseaseIntensive CareCerebral Blood FlowNephrology
Endothelial dysfunction and vascular biology emerge as unifying bases for stroke risk, progression, and cerebral perfusion, tying hypertension, atherogenesis, and fibrinolysis to outcomes. Preventive and acute management trials reflect a shift toward population- and protocol-driven strategies to avert stroke, with emphasis on antithrombotic regimens, AF-related risk, and early reperfusion balanced against hemorrhagic risk. Animal models and mechanistic studies delineate ischemic injury dynamics, elucidating roles of ischemic thresholds (penumbra) and early neuropathology for translation to therapies. Carotid disease investigations link imaging biomarkers, surgical interventions, and atherosclerotic progression to stroke prevention. Recovery and rehabilitation after stroke emphasize functional restoration and neuropsychological support in the early months, shaping post-stroke care pathways.
This period institutionalizes a vascular-centered perspective that bridges pathophysiology with practical interventions—thrombolysis, endarterectomy, and rehabilitation—accelerating the adoption of imaging-guided reperfusion protocols and standardized outcome measures. Breakthroughs in reperfusion therapy and carotid prevention redefine eligibility criteria and study designs, laying the groundwork for modern stroke management characterized by timely intervention, vascular risk modification, and integrated rehabilitation.
1998–2008
Cardiovascular DiseaseVascular BiologyCardiovascular ResearchThrombosisCardiologyStroke RehabilitationCerebrovascular DiseaseVascular SurgeryIntensive CareCerebral Blood Flow
The period centralized rapid reperfusion therapy for acute ischemic stroke and promoted systematic, guideline-driven care, while risk-based antithrombotic strategies in atrial fibrillation and vascular prevention with statins and renin-angiotensin blockers shaped stroke risk management. Imaging-based risk stratification and standardized protocols complemented pharmacologic prevention, creating an integrated approach to AF, MI, and stroke.
Pivotal trials and syntheses defined enduring practice: intravenous alteplase within the 3–4.5 hour window transformed treatment paradigms; imaging advances and inflammatory risk markers refined prediction and prevention; population-level data updates informed public health priorities and guideline development.
2009–2015
Cardiovascular DiseaseVascular BiologyStroke RehabilitationThrombosisCardiovascular ResearchCerebrovascular DiseaseIntensive CareCardiologyCerebral Blood FlowVascular Surgery
The period saw a shift from warfarin toward non–vitamin K antagonist oral anticoagulants for atrial fibrillation–related stroke prevention, with dabigatran and apixaban offering favorable safety profiles and simpler use. Guideline-driven risk stratification and therapy indications evolved to balance ischemic protection with bleeding risk. Interventional and device-based strategies, including endovascular thrombectomy and left atrial appendage considerations, integrated with imaging-guided pathways to optimize acute stroke care.
Key trials demonstrated non–vitamin K antagonist oral anticoagulants provide effective stroke prevention with reduced intracranial hemorrhage risk compared with warfarin. Perfusion-imaging–based selection and randomized endovascular thrombectomy trials redefined acute ischemic stroke management, promoting rapid reperfusion and standardized imaging-guided pathways. Collectively, these advances established a dual paradigm for prevention and treatment that shaped guidelines and clinical practice for years to come.
2016–2023
Cardiovascular DiseaseStroke RehabilitationVascular BiologyThrombosisCardiovascular ResearchIntensive CareCerebrovascular DiseaseCerebral Blood FlowCardiologyNeurovascular Disease
Perfusion-imaging guided selection solidified endovascular reperfusion as standard, enabling mechanical thrombectomy in extended and unknown onset windows. Simultaneously, cross-cutting guidelines in atrial fibrillation, peripheral arterial disease, and antiplatelet therapy standardized stroke risk management and cardiovascular care, informing practice and policy. Global epidemiology and prevention surveillance shaped prevention priorities, while peri-procedural antithrombotic strategies balanced ischemic and bleeding risks in acute care.
The period marks a paradigm shift from time-based thresholds to tissue-based decision criteria, driven by trials showing substantial functional gains up to 24 hours. Influential guidelines and statistics reports codified new risk stratification and prevention targets, consolidating perfusion-guided thrombectomy as standard. This unification of imaging, guideline consensus, and epidemiology reshaped global stroke care and policy for years to come.